Home > > > News

New Nonstimulant on the Horizon

A major pharmaceutical company announces positive results from testing of an extended-release nonstimulant.

Tuesday May 19th - 4:24pm

At an American Psychiatric Association meeting on Monday, the pharmaceutical company Shire announced positive results from the most recent round of tests of the extended-release drug, Intuniv. In particular, the company said the drug showed "significant" improvement in "oppositional" symptoms exhibited by some children with ADHD, such as defiant or angry behavior. Shire is now awaiting FDA approval of the medication.

Intuniv is an extended release form of guanfacine, a nonstimulant medication used to treat hypertension. Some doctors have used guanfacine off-label to treat ADHD in people who have trouble tolerating stimulants.

Read more about Intuniv.

What do you think of this article? Share your comments on www.ADDConnect.com, ADDitude's community site. Check out the new ADHD Medication User Reviews and the ADHD Adults Support Group. Your fellow ADDers want to hear from you!

Copyright © 1998 - 2013 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 39 W. 37th Street, 15th Floor, New York, NY 10018